All In MedTech

FDA Clearance Tracker · P030016-S019

VISIAN ICL

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: May 5, 2011 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

May 5, 2011

Approved

Time to decision

133 days

Received Dec 23, 2010. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P030016-S019
Device name
VISIAN ICL
Applicant location
Monrovia, CA
Received
Dec 23, 2010
Decided
May 5, 2011
Decision
Approved
Supplement type
Normal 180 Day Track
Original approval
P030016

Device type

Device class
Class III
Specialty
Ophthalmology

Every decision under product code MTA

FDA's approval statement

As written in FDA's record.

APPROVAL OF THE POST-APPROVAL STUDY PROTOCOL.

Source documents

Other decisions for STAAR Surgical Company

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

3 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.